arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

ORAGENICS INC

OGEN
$0.54 0.00 (-0.48%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
66 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
17
Health
Poor
Bearish
auto_awesome

Analytical Summary

ORAGENICS INC faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $2.3M
Dividend Yield
Revenue Growth None
Op. Margin None
ROIC -36.1%
FCF / Share $-0.51
Trailing P/E
Price / Book 0.4x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 6, 2026.

66-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$0.00
↓ -100.0%
Net Income Profit after all expenses
$-2.20M
↑ +0.7%
Operating Margin Operating profit as % of sales
-356.3%
↑ +22.8%
FCF / Share Free cash flow per share
$-0.51
↓ -341.3%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
7
Financial Health
7
Cash Quality
63

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 17 years · 66 quarters